Product correctly added to cart.

discount label
Mosapride Citrate
View 3D

Targetmol logo

Mosapride Citrate

CAS: 112885-42-4

Ref. TM-T6597

10mg
50.00 €
25mg
68.00 €
50mg
113.00 €
100mg
172.00 €
200mg
248.00 €
500mg
417.00 €
1ml*10 (DMSO)
52.00 €
Estimated delivery in United States, on Monday 13 May 2024

Product Information

Name:
Mosapride Citrate
Synonyms:
  • TAK-370 citrate, AS-4370 citrate, AS-4370
  • (+-)-4-Amino-5-Chloro-2-Ethoxy-N-((4-(4-Fluorobenzyl)-2-Morpholinyl)Methyl)B
  • 4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide 2-hydroxypropane-1,2,3-tricarboxylate (1:1)
  • 4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide 2-hydroxypropane-1,2,3-tricarboxylate dihydrate (salt)
  • As 4370
  • As4370
  • Benzamide, 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • Benzamide,4-Amino-5-Chloro-2-Ethoxy-N-((4-((4-Fluorophenyl)Methyl)-2-Morpholin
  • Enzamidecitrate
  • Gasmotin
  • See more synonyms
  • Mosid MT
  • Yl)Methyl)-,2-Hydroxy-1,2,3-Propanetricarboxylate(1:1)
Description:

Mosapride Citrate (TAK-370 citrate), a gastroprokinetic agent, utilizes as a selective 5HT4 agonist.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
614.02
Formula:
C21H25ClFN3O3·C6H8O7
Purity:
99.88%
Color/Form:
White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T6597 Mosapride Citrate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".